Veeda Clinical Research represents a truly international early clinical development CRO. The joining of Phase I Clinical Trials Unit (UK), ClinSearch Labs (India), DICE (Belgium) and Medifacts Phase I Unit (Germany) has resulted in a Company which can offer a complementary range of services to the Pharmaceutical Industry merging the experience and quality of the West with the speed and economies of the East.

Phase 1 Clinical Trials Unit Ltd was established in 1987 and quickly gained a reputation in the industry for its capacity to perform demanding phase I studies on time and to the highest standards. An uncompromising commitment to quality, excellent client relationships and reliable and timely volunteer recruitment has led major clients to regard Veeda CR as a preferred provider of phase I expertise.

The ClinSearch Labs pharmacology unit in Ahmedabad is a state of the art facility, conceived and designed to meet the diverse requirements of clients. In its first six months of business the unit had successfully completed 19 PK studies.

The Gorlitz unit was founded in 1992 as a 40-bed phase I facility equipped to conduct sophisticated pharmacokinetics trials in specific target populations, food/drug interaction studies, pharmacodynamic investigations, and dose ranging in patients.

Data Investigation Company Europe (DICE), located in Brussels, was established in 1989. Grown out of an academic environment, with its key people being highly qualified professional still having strong links to the academic world, this unit focuses on delivering data and results to the highest quality standards. This uncompromising commitment to quality has led to an enviable reputation and has entailed long-lasting client relationships.

The dedication of its highly trained staff and the dynamism and value system that permeates its activities sets Veeda Clinical Research apart from any other CRO.

“To be a global partner in the discovery and development of drugs in order to preserve and improve the quality of human life.”